Nothing Special   »   [go: up one dir, main page]

AU2015224504B2 - Peptides and compositions for prevention of cell adhesion and methods of using same - Google Patents

Peptides and compositions for prevention of cell adhesion and methods of using same

Info

Publication number
AU2015224504B2
AU2015224504B2 AU2015224504A AU2015224504A AU2015224504B2 AU 2015224504 B2 AU2015224504 B2 AU 2015224504B2 AU 2015224504 A AU2015224504 A AU 2015224504A AU 2015224504 A AU2015224504 A AU 2015224504A AU 2015224504 B2 AU2015224504 B2 AU 2015224504B2
Authority
AU
Australia
Prior art keywords
prevention
compositions
methods
same
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015224504A
Other versions
AU2015224504A1 (en
Inventor
Amir Zlotkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tel HaShomer Medical Research Infrastructure and Services Ltd
Original Assignee
Tel HaShomer Medical Research Infrastructure and Services Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009334452A external-priority patent/AU2009334452B2/en
Application filed by Tel HaShomer Medical Research Infrastructure and Services Ltd filed Critical Tel HaShomer Medical Research Infrastructure and Services Ltd
Priority to AU2015224504A priority Critical patent/AU2015224504B2/en
Publication of AU2015224504A1 publication Critical patent/AU2015224504A1/en
Application granted granted Critical
Publication of AU2015224504B2 publication Critical patent/AU2015224504B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

Abstract The present invention relates to compositions comprising an isolated peptide, which may for example optionally comprise a sequence selected from the group consisting of FDYDWY, SFSQNKSVHSFDYDWYNVSDQADLKN or CSFSQNKSVHSFDYDWYNVS-DQADLKNC, or 5 any cyclized version thereof, and methods of using same, including for treatment of or prevention of formation of microbial biofilms and against adhesion of a cell to a surface. WO 2010/076642 PCT/1B2009/007896 oc U) U)00 cm n N~
AU2015224504A 2008-12-29 2015-09-11 Peptides and compositions for prevention of cell adhesion and methods of using same Active AU2015224504B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2015224504A AU2015224504B2 (en) 2008-12-29 2015-09-11 Peptides and compositions for prevention of cell adhesion and methods of using same

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19382108P 2008-12-29 2008-12-29
US61/193,821 2008-12-29
AU2009334452A AU2009334452B2 (en) 2008-12-29 2009-12-28 Peptides and compositions for prevention of cell adhesion and methods of using same
PCT/IB2009/007896 WO2010076642A1 (en) 2008-12-29 2009-12-28 Peptides and compositions for prevention of cell adhesion and methods of using same
AU2015224504A AU2015224504B2 (en) 2008-12-29 2015-09-11 Peptides and compositions for prevention of cell adhesion and methods of using same

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2009334452A Division AU2009334452B2 (en) 2008-12-29 2009-12-28 Peptides and compositions for prevention of cell adhesion and methods of using same

Publications (2)

Publication Number Publication Date
AU2015224504A1 AU2015224504A1 (en) 2015-10-01
AU2015224504B2 true AU2015224504B2 (en) 2018-02-22

Family

ID=54251837

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015224504A Active AU2015224504B2 (en) 2008-12-29 2015-09-11 Peptides and compositions for prevention of cell adhesion and methods of using same

Country Status (1)

Country Link
AU (1) AU2015224504B2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003006048A1 (en) * 2001-07-11 2003-01-23 Jari Pharmaceuticals B.V. Combination of chips (chemotaxis inhibiting protein from staphylococcus aureus)-based compounds
WO2005121778A2 (en) * 2004-06-14 2005-12-22 Galapagos N.V. Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003006048A1 (en) * 2001-07-11 2003-01-23 Jari Pharmaceuticals B.V. Combination of chips (chemotaxis inhibiting protein from staphylococcus aureus)-based compounds
WO2005121778A2 (en) * 2004-06-14 2005-12-22 Galapagos N.V. Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases

Also Published As

Publication number Publication date
AU2015224504A1 (en) 2015-10-01

Similar Documents

Publication Publication Date Title
WO2010035107A3 (en) Peptides and compositions for prevention of cell adhesion and methods of using same
WO2009059325A3 (en) Multitype hpv peptide compositions and methods for treatment or prevention of human papillomavirus infection
WO2010034032A3 (en) Methods for preparing purified polypeptide compositions
WO2009082701A8 (en) Hcv protease inhibitors and uses thereof
MX2010006736A (en) Hcv protease inhibitors and uses thereof.
WO2009156462A3 (en) Organic compounds
MY161495A (en) Virus like particle compositions and methods of use
HK1129581A1 (en)
WO2011032169A3 (en) Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
AU2009236256A8 (en) Small molecule inhibitors of the pleckstrin homology domain and methods for using same
WO2006116424A3 (en) Paintable nanofiber coatings
WO2008049116A3 (en) Substituted indoles
WO2008067145A3 (en) Self-assembling peptide amphiphiles
WO2009042114A3 (en) Phenazine derivatives and uses thereof
WO2008013589A3 (en) Treatment of ras-expressing tumors
WO2010034015A3 (en) Modulating the alternative complement pathway
MX2007008723A (en) Yersinia spp. polypeptides and methods of use.
WO2008112368A3 (en) Phenylalkylcarboxylic acid delivery agents
WO2008104979A3 (en) Nuclear targeting sequences
GB201001602D0 (en) Oligopeptidic compounds and uses therof
WO2010142551A8 (en) Amino acid sequences directed against receptors to cytokines belonging to the il-17 family
WO2010053573A3 (en) Screen for inhibitors of filovirus and uses therefor
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
WO2008112903A3 (en) Genetic alterations on chromosome 16 and methods of use thereof for the diagnosis and treatment of type 1 diabetes
WO2010000851A3 (en) Methods for modulating angiogenesis via dystrophin dp71

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted
NA Applications received for extensions of time, section 223

Free format text: AN APPLICATION TO EXTEND THE TIME FROM 05 MAY 2017 TO 06 JAN 2018 IN WHICH TO GAIN ACCEPTANCE HAS BEEN FILED

NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO GAIN ACCEPTANCE HAS BEEN EXTENDED TO 06 JAN 2018

FGA Letters patent sealed or granted (standard patent)